Cirrus Therapeutics
PrivateLast Round
Seed
Oct 2, 2025
Total Funding Raised
$11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cirrus Therapeutics is a biotechnology company developing gene and cell therapies for ocular immunology to treat conditions like age-related macular degeneration (AMD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cirrus Therapeutics Comparables
Compare Cirrus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Complement Therapeutics GmbH | 84% | |
| Luxa Biotechnology | 81% | |
| Perceive Bio | 81% |
Cirrus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 2, 2025 |
Key People
Founding team and executive leadership
Cirrus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Seed |
| ClavystBio | Seed |
| Polaris Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 562% MoM.
- Jun 27, 2026
Grew 33% QoQ, from 9 to 12 employees.
Cirrus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cirrus Therapeutics's valuation, stock price, and market status.
Is Cirrus Therapeutics a public or private company?
Cirrus Therapeutics is a private company.
What is the current stock price of Cirrus Therapeutics?
Cirrus Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Cirrus Therapeutics worth (valuation)?
Valuation information for Cirrus Therapeutics is not publicly available.
Can I buy Cirrus Therapeutics stock?
Cirrus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cirrus Therapeutics's last funding round?
Cirrus Therapeutics's most recent funding round was Seed on October 2, 2025.
Who are the main investors in Cirrus Therapeutics?
Key investors in Cirrus Therapeutics include ClavystBio.
Will Cirrus Therapeutics IPO soon?
No public IPO plans have been announced for Cirrus Therapeutics.
How can I track Cirrus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cirrus Therapeutics's secondary market activity and sign up for updates.